BlueCrest Capital Management’s Trueblue TBI Stock Holding History

BlueCrest Capital Management’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-14,213	Closed	-$319K	–	1091
2017 Q3	$319K	Buy	+14,213	New	+$321K	0.01%	623

Other funds holding TBI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlueCrest Capital Management's TBI Position: Q4 2017 in Review

BlueCrest Capital Management sold out of Trueblue (TBI) in Q4 2017, closing a stake of 14,213 shares — an estimated $319K sold.

BlueCrest Capital Management first reported a position in TBI in Q3 2017 and held it in 1 quarter. The position peaked at $319K in Q3 2017. 200 funds tracked by Wall St. Rank hold TBI as of Q4 2017.

BlueCrest Capital Management reported no remaining Trueblue position as of Q4 2017 after selling out during the quarter.
BlueCrest Capital Management sold 14,213 Trueblue shares in Q4 2017, an estimated $319K.
BlueCrest Capital Management first reported a position in Trueblue in Q3 2017 and held it in 1 quarter.
BlueCrest Capital Management's Trueblue position peaked at $319K in Q3 2017.
200 funds tracked by Wall St. Rank held Trueblue as of Q4 2017.

Based on BlueCrest Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.